Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SPRC
- Price
- 6.22
- Stock movement up
- +1.26 (1.44%)
- Company name
- Scisparc Ltd
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 144.11M
- Ent value
- 143.63M
- Price/Sales
- 34.10
- Price/Book
- 15.03
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 55.27%
- 1 year return
- -97.72%
- 3 year return
- -92.68%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
SPRC does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 34.10 |
| Price to Book | 15.03 |
| EV to Sales | 33.99 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.62M |
| EPS (TTM) | -58.09 |
| FCF per share (TTM) | -489.87 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 4.23M |
| Gross profit (TTM) | 1.89M |
| Operating income (TTM) | -9.83M |
| Net income (TTM) | -1.96M |
| EPS (TTM) | -58.09 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 44.65% |
| Operating margin (TTM) | -232.63% |
| Profit margin (TTM) | -46.26% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.08M |
| Net receivables | 287.00K |
| Total current assets | 6.45M |
| Goodwill | 0.00 |
| Intangible assets | 3.19M |
| Property, plant and equipment | 0.00 |
| Total assets | 11.18M |
| Accounts payable | 264.00K |
| Short/Current long term debt | 76.00K |
| Total current liabilities | 1.57M |
| Total liabilities | 1.59M |
| Shareholder's equity | 9.59M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -11.62M |
| Capital expenditures (TTM) | 4.87M |
| Free cash flow (TTM) | -16.48M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -20.39% |
| Return on Assets | -17.48% |
| Return on Invested Capital | -20.28% |
| Cash Return on Invested Capital | -171.02% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 87.57 |
| Daily high | 92.61 |
| Daily low | 87.57 |
| Daily Volume | 2K |
| All-time high | 1854052.20 |
| 1y analyst estimate | - |
| Beta | 0.95 |
| EPS (TTM) | -58.09 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SPRC | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.46% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 20 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -82.02% | -10.99% |
| Avg time to new high | 59 days | 12 days |
| Max time to new high | 950 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
144.11M
Marketcap category
Small-cap
Description
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. It also sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufacture SCI-110, palmitoylethanolamide oral tablets and CannAmide in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.
Employees
2
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page